TransMedics TMDX
NASDAQ TMDX
$90.70 -3.27 (-3.48%)
As of: Aug 20, 2026 · 3:59 PM EDT

TransMedics (TMDX) Total Non-Current Liabilities (2022 - 2026)

TransMedics (TMDX) posted quarterly Total Non-Current Liabilities of $936.8 million for Q1 2026, up 66.47% quarter-over-quarter from $562.8 million in Q3 2023.

TransMedics (TMDX) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends

TransMedics' Total Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $936.8 million for Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities changed N/A year-over-year to $936.8 million; the TTM figure through Mar 2026 stood at $936.8 million (changed N/A YoY), while the FY2022 annual figure was $89.8 million, changed N/A from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $936.8 million, up from $562.8 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $936.8 million in Q1 2026, with the low at $89.8 million in Q4 2022.
  • The 3-year median for Total Non-Current Liabilities is $545.1 million (2023), against an average of $445.8 million.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 21.28 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 40.90 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 42.74 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 2.57 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 3.68 Bn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 23.89 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 9.07 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 3.44 Bn
10 TransMedics 3.15 Bn 2.67 Bn 113.20 Mn 942.36 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 942.36 Mn
Mar 31, 2026 936.83 Mn
Sep 30, 2023 562.77 Mn
Jun 30, 2023 545.15 Mn
Mar 31, 2023 94.46 Mn
Dec 31, 2022 89.77 Mn